Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma
Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The goal of this study is to prospectively follow the level of circulating nucleosomes in patients treated for a non-Hodgkin lymphoma and determine whether it correlates with the clinical response.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Histologically proven diagnosis of diffuse large B cell lymphoma or follicular lymphoma, according to the WHO 2016 classification, requiring a first line of treatment with a RCHOP 21 regimen
• Agreement to participate after receiving oral and written information on the study
Locations
Other Locations
France
Gustave Roussy
RECRUITING
Villejuif
Contact Information
Primary
David GHEZ
david.ghez@gustaveroussy.fr
+33 1 42 11 42 40
Backup
Christophe MARZAC
christophe.marzac@gustaveroussy.fr
+33 1 42 11 51 31
Time Frame
Start Date: 2024-09-30
Estimated Completion Date: 2029-10
Participants
Target number of participants: 50
Treatments
Experimental: Patients receiving first line of treatment with a RCHOP 21 regimen
All patients will receive first line of treatment with a RCHOP 21 regimen
Related Therapeutic Areas
Sponsors
Leads: Gustave Roussy, Cancer Campus, Grand Paris